Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer

NCT06455046 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

37

Enrollment

OTHER_GOV

Sponsor class

Conditions

Cervical Cancer Recurrent

Interventions

DRUG: AK104
DRUG: Recombinant Human Adenovirus 5 Injection

Sponsor

Fujian Cancer Hospital

Collaborators

[object Object]